You are here: Industry Insights > NHS

News List

Pfizer wins blockbuster Lyrica patent extension to safeguard sales till June fiercepharma
December 06, 2018
Pfizer, looking to protect billions in Lyrica sales, has been gunning for a 6-month pediatric exclusivity extension for its top drug. And on Tuesday, the FDA came through in favor of the drugmaker.
Diabetes drugs cost NHS more than £1bn a year pharmaphorum
December 04, 2018
Diabetes prescriptions are costing the NHS in England more than £1 billion a year, driven by an increase in the number of patients rather than rising drug costs.
NHS to trial low calorie diets to combat type II diabetes pharmatimes
December 03, 2018
Hundreds of thousands of people will receive NHS help to battle obesity and type II diabetes under radical action set out by Simon Stevens, chief executive of NHS England.
NHS saving £300m with Humira biosimilar deal pharmaphorum
November 30, 2018
The NHS is to save £300 million after striking deals with several manufacturers of low cost biosimilars of AbbVie’s Humira inflammatory diseases drug.....
NICE recommends Bayer's Stivarga for advanced hepatocellular carcinoma pharmafile
November 30, 2018
The National Institute for Health and Care Excellence (NICE) has voiced its recommendation for Bayer’s Stivarga (regorafenib) for use on the NHS in England and Wales in the treatment of advanced unresectable hepatocellular carcinoma (HCC)...
NHS cracks down on low-priority prescriptions pharmatimes
November 29, 2018
A new NHS report has named medicines set to be subject to cutbacks, which have been proven to be ineffective or in some cases dangerous, and for which there are other more effective...
NHS to save £300 million by switching to Humira biosimilars pharmafile
November 28, 2018
NHS England has announced that the health service is set to save £300 million by switching to biosimilar versions of AbbVie’s best-selling anti-inflammatory drug Humira (adalimumab)
Seqirus to spend $140M in N.C. flu vaccine plant expansion pharmaphorum
November 28, 2018
The performance of NHS cancer services in England is lagging behind those of comparable countries, according to a new report.
First children set to receive Novartis’ Kymriah pharmatimes
November 28, 2018
The first children to receive Novartis’ Kymriah – a ‘game-changing’ CAR-T therapy for cancer - will start treatment at Great Ormond Street Hospital in London this week, NHS England has announced.
NHS lags best performers in cancer care – report pharmaphorum
November 28, 2018
The performance of NHS cancer services in England is lagging behind those of comparable countries, according to a new report.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 44 45 Next page